Press Release

Printer Friendly Version View printer-friendly version
<< Back
POZEN To Present at the UBS 2006 Global Life Sciences Conference

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Sept. 13, 2006--POZEN Inc. (NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the company's chairman, president and chief executive officer, will present at the UBS 2006 Global Life Sciences Conference on Monday, September 25, 2006 at 10:30 a.m. at the Grand Hyatt in New York City. Dr. Plachetka's presentation will be webcast and archived on POZEN's home page at www.pozen.com.

POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. POZEN's efforts are focused primarily on the development of pharmaceutical products for the treatment of acute and chronic pain and other pain-related conditions. POZEN has development and commercialization alliances with GlaxoSmithKline and AstraZeneca. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.

CONTACT: POZEN Inc.
Bill Hodges
Chief Financial Officer
919-913-1030
or
Fran Barsky
Director, Investor Relations
919-913-1044

SOURCE: POZEN


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.